Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,035 USD | +17,18% | +3,58% | +78,53% |
14:00 | HERON THERAPEUTICS, INC. : Capital One Securities ontvangt een koopadvies | ZM |
21/03 | Heron Therapeutics, Inc. Kondigt wijzigingen in de leiding aan, met ingang van 29 maart 2024 | CI |
Omzet 2024 * | 146 mln. 136 mln. | Omzet 2025 * | 176 mln. 164 mln. | Marktkapitalisatie | 389 mln. 364 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -32 mln. -29,91 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,41 mln. | EV/omzet 2024 * | 2,67 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,22 x |
K/w-verhouding 2024 * |
-12,1
x | K/w-verhouding 2025 * |
-40,9
x | Werknemers | 126 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,07% |
Recentste transcriptie over Heron Therapeutics, Inc.
1 dag | +17,18% | ||
1 week | +3,58% | ||
Lopende maand | +9,57% | ||
1 maand | +2,88% | ||
3 maanden | +37,95% | ||
6 maanden | +404,49% | ||
Lopend jaar | +78,53% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21-02-23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16-06-23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-11-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21-02-23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20-09-21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13-01-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 3,035 | +17,18% | 4 329 396 |
22-04-24 | 2,59 | -1,89% | 2 089 310 |
19-04-24 | 2,64 | -2,58% | 2 308 607 |
18-04-24 | 2,71 | -2,17% | 1 818 101 |
17-04-24 | 2,77 | -5,46% | 1 557 084 |
uitgestelde koers Nasdaq, 23 april 2024 om 18:56 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+78,53% | 389 mln. | |
+1,92% | 42,11 mld. | |
+48,83% | 40,08 mld. | |
+8,22% | 40 mld. | |
-10,82% | 26,87 mld. | |
+7,74% | 24,58 mld. | |
-23,48% | 18,44 mld. | |
+1,55% | 11,94 mld. | |
+31,78% | 11,66 mld. | |
+7,44% | 11,01 mld. |